Lunai Bioworks Inc.

LNAI

NASDAQ

Healthcare

Biotechnology

Los Angeles, CA, US29 employeesrenovarogroup.com

$0.38

-0.03(-8.23%)

Mkt Cap $7M

$0.18

$2.28

52-Week Range

At a Glance

AI-generated

8-K

Lunai Bioworks entered debt exchange agreements to convert $828,770 of notes into 3.9M common shares and warrants, and a binding agreement for $20M preferred stock investment to acquire BBB delivery technology for CNS Alzheimer’s assets.

$7M

Market Cap

—

Revenue

-$95M

Net Income

Employees29

Fundamentals

How The Business Makes Money

A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.

Industry Biotechnology

Activity

What Changed Recently

Delisting

Feb 22, 2026

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 6, 2026, Lunai Bioworks Inc. (the “Company”) re

Delisting

Feb 11, 2026

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 6, 2026, Lunai Bioworks, Inc. (the “Company”) r

Material Agreement+3 More

Mar 29, 2026

Entry into a Material Definitive Agreement** On March 24, 2026, Lunai Bioworks, Inc. (the “Company”) entered into separate debt exchange agreements (collectivel

Other Event

Mar 4, 2026

Other Events. On February 27, 2026, Lunai Bioworks Inc. (the “Company”) implemented a temporary furlough of its employees in the United States and Canada as par

Peer Companies

Company	Price	Change	Market Cap	P/E
ANLAdlai Nortye Ltd.	$8.65	+9.56%	$270M	-1.4
THARTharimmune, Inc.	$3.29	+6.82%	$130M	-2.0
ADAPADAP	$0.05	-3.00%	$75M	—
APLMApollomics, Inc.	$14.95	+1.53%	$16M	-0.6
ICUSeaStar Medical Holding C...	$4.46	+25.42%	$12M	-0.4
LPCNLipocine Inc.	$2.02	-78.14%	$11M	-4.1
BLRXBioLineRx Ltd.	$2.21	+1.50%	$10M	-3.3
MBRXMoleculin Biotech, Inc.	$2.32	+4.04%	$3M	-1.0

Company Profile

CIK0001527728

ISINUS29350E2037

CUSIP29350E203

Phone305 918 1980

Address2080 Century Park East, Los Angeles, CA, 90067, US

SEC EDGAR